Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10345-3 | Torkinib | PP242 | LSM-6357 |  | 57347681 |
| 10240-1 | AS-252424 | LSM-4263 |  | 56965900 | |
| 10021-5 | Tozasertib | VX680; MK-0457 | LSM-1021 |  | 5494449 |
| 10275-1 | (Z)-4-Hydroxytamoxifen | LSM-43294 |  | 53770298 | |
| 10235-2 | Everolimus | RAD001 | LSM-4258 |  | 53398658 |
| 10189-2 | Bosutinib | SKI-606 | LSM-1190 |  | 5328940 |
| 10281-1 | Vinorelbine | Navelbine | LSM-6302 |  | 5311497 |
| 10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 |  | 5311 |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10023-3 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 |  | 5291 |
| 10343-1 | Baicalein | LSM-6355 |  | 5281605 | |
| 10242-1 | Carboplatin | LSM-44959 |  | 5237030 | |
| 10052-3 | Sirolimus | Rapamycin | LSM-1052 |  | 5040 |
| 10243-1 | CGC-11047 | PG11047 | LSM-4266 |  | 476863 |
| 10271-2 | PD 98059 | LSM-3394 |  | 4713 | |
| 10062-3 | GSK1070916 | KIN001-216 | LSM-1062 |  | 46885626 |
| 10107-2 | MG-132 | LSM-1107 |  | 462382 | |
| 10107 | MG-132 | LSM-1107 |  | 462382 | |
| 10107-5 | MG-132 | LSM-1107 | | 462382 | |
| 10270-1 | Oxamflatin | LSM-4290 |  | 4611 | |
| 10267-1 | NU6102 | LSM-4287 |  | 4566 | |
| 10273-1 | Purvalanol A | LSM-3118 |  | 456214 | |
| 10258-1 | Ibandronate | Boniva | LSM-4279 |  | 44828485 |
| 10272-1 | Pemetrexed | Alimta | LSM-6353 |  | 446556 |